Mobocertinib in NSCLC With EGFR Exon 20 Insertions: Results From EXCLAIM and Pooled Platinum-Pretreated Patient Populations Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Zhou, C.; Ramalingam, S.; Li, B.; Fang, J.; Kim, T. M.; Kim, S.; Yang, J. C.; Riely, G.; Mekhail, T.; Nguyen, D.; Garcia Campelo, M. R.; Felip, E.; Jin, S.; Bunn, V.; Lin, J.; Lin, H.; Mehta, M.; Janne, P.

Publication Date

  • March 1, 2021

webpage

published in

category

keywords

  • EGFR exon 20 insertions
  • mobocertinib
  • non-small cell lung cancer

start page

  • S108

end page

  • S108

volume

  • 16

issue

  • 3